Biotech

All Articles

Bicara, Zenas find IPOs to drive late-phase properties towards market

.Bicara Therapies and Zenas Biopharma have provided fresh incentive to the IPO market with filings t...

Genentech to close cancer immunology study division

.Genentech will close its cancer immunology research department, as well as unit mind and well-known...

Kezar loses solid tumor but to verify its truly worth in stage 1 test

.Kezar Life Sciences is losing its unpromising phase 1 solid tumor drug as the biotech goes all-in o...

Acelyrin loses izokibep, lays off 3rd of staff

.Despite izokibep maintaining its own newly found winning touch in the facility, Acelyrin is no long...

Rivus' stage 2 obesity-related cardiac arrest trial attacks endpoint

.Rivus Pharmaceuticals has actually plumped up the potential customers of its fat-busting, muscle-sp...

Ovid standstills preclinical work, IV system after soticlestat stop working

.Ovid Therapeutics currently uncovered final month that it was trimming its head count as the busine...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston ma Seaport

.Eli Lilly has opened a $700 thousand R&ampD center in the Boston ma Seaport, improving its RNA and ...

Boundless Biography makes 'small' unemployments 5 months after $100M IPO

.Just 5 months after protecting a $one hundred million IPO, Vast Bio is actually currently laying of...

Halda's $126M will definitely accelerate 'secure as well as eliminate' lump medicines

.The first stages of oncology R&ampD aren't except intriguing brand new methods, as well as Halda Re...

Lykos 'remorses' not divulging research study offenses with author

.Psychopharmacology has actually drawn three short articles about midstage clinical test data analyz...